TY  - GEN
AU  - Belshe,R B
AU  - Gorse,G J
AU  - Mulligan,M J
AU  - Evans,T G
AU  - Keefer,M C
AU  - Excler,J L
AU  - Duliege,A M
AU  - Tartaglia,J
AU  - Cox,W I
AU  - McNamara,J
AU  - Hwang,K L
AU  - Bradney,A
AU  - Montefiori,D
AU  - Weinhold,K J
TI  - Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group
SN  - 0269-9370
PY  - 1999///0714
KW  - AIDS Vaccines
KW  - adverse effects
KW  - Adolescent
KW  - Adult
KW  - Avipoxvirus
KW  - immunology
KW  - CD8-Positive T-Lymphocytes
KW  - Double-Blind Method
KW  - HIV Antibodies
KW  - blood
KW  - HIV Envelope Protein gp120
KW  - HIV Infections
KW  - prevention & control
KW  - HIV-1
KW  - Humans
KW  - Immunization Schedule
KW  - Middle Aged
KW  - Neutralization Tests
KW  - Peptide Fragments
KW  - Prospective Studies
KW  - T-Lymphocytes, Cytotoxic
KW  - Vaccines, Synthetic
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1097/00002030-199818000-00009
ER  -